Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic polymorphisms of CYP2D6 oxidation in patients with inflammatory bowel disease.

Digestive diseases and sciences - 1 Apr 2010

Trzcinski R, Skretkowicz J, Dziki A, Rychlik-Sych M, Baranska M

Abstract excerpt

Inflammatory bowel disease (IBD) consists of ulcerative colitis and Crohn's disease, both of which are associated with increased colorectal cancer risk. The relationship between genetically determined polymorphic metabolism of exogenous substances by oxidation catalyzed by CYP2D6 isoenzyme and susceptibility to cancer has aroused great interest. We determined whether there was an association between...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colitis, Ulcerative
Share to Colorectal Neoplasms
Share to Crohn Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P-450 CYP2D6

Share to DNA Mutational Analysis

Share to Genetic Carrier Screening

Share to Oxidation-Reduction

Share to Polymorphism, Restriction Fragment Length

Source

Identifiers

PMID: 19437119
DOI: 10.1007/s10620-009-0816-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic polymorphisms of CYP2D6 oxidation in patients with inflammatory bowel disease.PMID 19437119Read ↗

Significance of the genetic polymorphism of CYP2D6 and NAT2 in patients with inflammatory bowel diseases.Semantic proximity Read ↗

Debrisoquine oxidation polymorphism in patients with chronic inflammatory bowel disease.Semantic proximity Read ↗

[Significance of CYP2D6 oxidation genotype as a risk factor in development of allergic diseases].Semantic proximity Read ↗

Common polymorphisms in the microsomal epoxide hydrolase and N-acetyltransferase 2 genes in association with inflammatory bowel disease in the Danish population.Semantic proximity Read ↗

Evaluation of CYP2D6 Protein Expression and Activity in the Small Intestine to Determine Its Metabolic Capability in the Japanese Population.Semantic proximity Read ↗

CYP2C19 polymorphism has no correlation with the efficacy and safety of thalidomide in the treatment of immune-related bowel disease.Semantic proximity Read ↗

The CYP2D6 extensive metabolizer genotype is associated with increased risk for bladder cancer.Semantic proximity Read ↗

Phenotype of cytochrome P450 CYP2D6 in patients with familial adenomatous polyposis.Semantic proximity Read ↗

Genetic polymorphisms of CYP2D6 oxidation in patients with systemic sclerosis.Semantic proximity Read ↗

Genetic polymorphisms in biotransformation enzymes in Crohn's disease: association with microsomal epoxide hydrolase.Semantic proximity Read ↗

Significance of genetic polymorphism of CYP2D6 in the pathogenesis of systemic sclerosis.Semantic proximity Read ↗

Interleukin-6 mediated upregulation of CYP1B1 and CYP2E1 in colorectal cancer involves DNA methylation, miR27b and STAT3Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.